{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:10:29Z","timestamp":1791421829421,"version":"4.3.3"},"reference-count":26,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008953","name":"Prometheus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008953","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinigen"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["OncoImmunology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1080\/2162402x.2021.1984059","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:14:30Z","timestamp":1633900470000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["An Open\u2013Label, Randomized, Multi\u2013Center Study Comparing the Sequence of High Dose Aldesleukin (Interleukin\u20132) and Ipilimumab (Yervoy) in Patients with Metastatic Melanoma"],"prefix":"10.1080","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6102-4917","authenticated-orcid":false,"given":"Merve","family":"Hasanov","sequence":"first","affiliation":[{"name":"The University of Texas Md Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Den\u00e1i R.","family":"Milton","sequence":"additional","affiliation":[{"name":"The University of Texas Md Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7766-249X","authenticated-orcid":false,"given":"William H.","family":"Sharfman","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University","place":["Lutherville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3440-5316","authenticated-orcid":false,"given":"Bret","family":"Taback","sequence":"additional","affiliation":[{"name":"New York-Presbyterian\/Columbia University Medical Center","place":["New York, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7789-5442","authenticated-orcid":false,"given":"Lee D.","family":"Cranmer","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center","place":["Seattle, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-8009","authenticated-orcid":false,"given":"Gregory A","family":"Daniels","sequence":"additional","affiliation":[{"name":"University of California San Diego","place":["La Jolla, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Flaherty","sequence":"additional","affiliation":[{"name":"Karmanos Cancer Institute, Wayne State University","place":["Detroit, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5342-2846","authenticated-orcid":false,"given":"Sigrun","family":"Hallmeyer","sequence":"additional","affiliation":[{"name":"Advocate Medical Group","place":["Park Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4663-6824","authenticated-orcid":false,"given":"Mohammed","family":"Milhem","sequence":"additional","affiliation":[{"name":"University of Iowa Hospitals and Clinics","place":["Iowa City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7310-2601","authenticated-orcid":false,"given":"Lynn","family":"Feun","sequence":"additional","affiliation":[{"name":"University of Miami Health System","place":["Miami, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0243-7279","authenticated-orcid":false,"given":"Ralph","family":"Hauke","sequence":"additional","affiliation":[{"name":"Nebraska Cancer Specialists","place":["Omaha, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9141-449X","authenticated-orcid":false,"given":"Gary","family":"Doolittle","sequence":"additional","affiliation":[{"name":"University of Kansas Medical Center","place":["Kansas City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Gregory","sequence":"additional","affiliation":[{"name":"Clinigen Group","place":["Yardley, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-1517","authenticated-orcid":false,"given":"Sapna","family":"Patel","sequence":"additional","affiliation":[{"name":"The University of Texas Md Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,10,9]]},"reference":[{"key":"e_1_3_8_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21590"},{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.7.2105"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21235"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910836"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.77.10.6134"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.181845"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198512053132327"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2016.07.006"},{"key":"e_1_3_8_10_1","first-page":"S11","article-title":"High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update","volume":"6","author":"Atkins MB","year":"2000","unstructured":"Atkins MB, Kunkel L, Sznol M. High-dose recombinant interleukin-2 therapy in patients with metastatic melanoma: long-term survival update. Cancer J Sci Am. 2000;6:S11\u20134.","journal-title":"Cancer J Sci Am"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60802-8"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.8954"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003466"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2005.03.536"},{"key":"e_1_3_8_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-1823"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1624"},{"key":"e_1_3_8_17_1","unstructured":"U.S. Department of Health and Human Services NIoH National Cancer Institute: Common terminology criteria for adverse events: (CTCAE) v4.03 CTCAE; 2010."},{"key":"e_1_3_8_18_1","unstructured":"SWOG: SWOG Statistical Center website statistical tools."},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30074-8"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-013-0025-9"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.01483"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-016-0155-8"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1412690"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq013"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-1024"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(09)70334-1"},{"key":"e_1_3_8_27_1","volume-title":"Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma","author":"ClinicalTrials.gov","year":"2020","unstructured":"ClinicalTrials.gov. Testing Treatment With Ipilimumab and Nivolumab Compared to Treatment With Ipilimumab Alone in Advanced Melanoma. 2020. ls.gov\/ct2\/show\/NCT03033576?term=NCT03033576&draw=2&rank=1"}],"container-title":["OncoImmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/2162402X.2021.1984059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T22:54:48Z","timestamp":1766098488000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/2162402X.2021.1984059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["10.1080\/2162402X.2021.1984059"],"URL":"https:\/\/doi.org\/10.1080\/2162402x.2021.1984059","relation":{},"ISSN":["2162-402X"],"issn-type":[{"value":"2162-402X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=koni20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-06-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"1984059"}}